Biologic May Tame Severe Asthma – MedPage Today


The Pharma Letter

Biologic May Tame Severe Asthma
MedPage Today
A. A. Take Posttest. SAN DIEGO — Lebrikizumab, a novel monoclonal antibody against the inflammatory cytokine IL-13, might have reduced exacerbations in severe asthma in a randomized trial, although manufacturing problems undermined any conclusions.
Roche drug cuts asthma attacks, improves lung function -studyReuters
Roche scores upbeat data for a personalized asthma drug with blockbuster hopesFierceBiotech
AAAAI 2014: Roche's lebrikizumab shows reduction of asthma attack ratesThe Pharma Letter
Drug Discovery & Development –PharmaTimes
all 11 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.